Results 111 to 120 of about 731 (176)

Deep learning methods for protein function prediction. [PDF]

Proteomics
Boadu F, Lee A, Cheng J.
europepmc   +1 more source

Magnetic activities of two contact binaries in quadruple stellar systems. [PDF]

Sci Rep
Yang Y, Wang S.
europepmc   +1 more source

JWST interferometric imaging reveals the dusty torus obscuring the supermassive black hole of Circinus galaxy. [PDF]

Nat Commun
Lopez-Rodriguez E, Sanchez-Bermudez J, González-Martín O, Nikutta R, Lau RM, Thatte D, García-Bernete I, Girard JH, Hankins MJ.   +8 more
europepmc   +1 more source

A direct black-hole mass measurement in a little red dot at high redshift. [PDF]

Nature
Juodžbalis I, Marconcini C, D'Eugenio F, Maiolino R, Marconi A, Übler H, Scholtz J, Ji X, Jones GC, Perna M, Arribas S, Bennett JS, Bromm V, Bunker AJ, Carniani S, Charlot S, Cresci G, Dayal P, Egami E, Fabian A, Inayoshi K, Isobe Y, Ivey LR, Koudmani S, Laporte N, Liu B, Lyu J, Mazzolari G, Monty S, Parlanti E, Pérez-González PG, Robertson B, Schneider R, Sijacki D, Tacchella S, Trinca A, Valiante R, Volonteri M, Witstok J, Zhang S.   +39 more
europepmc   +1 more source

Efficacy of Immune Checkpoint Blockade in Advanced Upper Tract Urothelial Cancer With DNA Mismatch Repair Deficiency or Microsatellite Instability. [PDF]

JCO Precis Oncol
Moussa MJ, Andreev-Drakhlin AY, Venkatesan AM, Matin SF, Xiao L, Tidwell RSS, Shah AY, Adriazola AC, Shaw L, Gao J, Lin JK, Goswami S, Msaouel P, Guo CC, Tannir NM, Siefker-Radtke AO, Alhalabi O, Campbell MT.   +17 more
europepmc   +1 more source

Avelumab maintenance treatment for advanced urothelial cancer: plain language summary of long-term results from the JAVELIN Bladder 100 study. [PDF]

Future Oncol
Powles T, Park SH, Gurney H, Loriot Y, Sridhar SS, Bellmunt J, di Pietro A, Grivas P.   +7 more
europepmc   +1 more source

Nivolumab plus gemcitabine-cisplatin for unresectable or metastatic urothelial carcinoma: health-related quality-of-life analyses from the phase III CheckMate 901 trial. [PDF]

ESMO Open
Bedke J, van der Heijden MS, Sonpavde G, Galsky MD, Liao W, Shi L, Blum SI, Mitra S, Patel MY, Powles T.   +9 more
europepmc   +1 more source

Implementing intervention mapping to tailor the evidence-based PREDIMED intervention for medically underserved prostate cancer patients. [PDF]

Transl Behav Med
Garcia RS, Daniel CR, Hwang C, Levy E, Smith M, Cho D, Frigo DE, Hahn AW, Ma H, Robert M, Pettaway C, Chapin BF, LaRue D, Canfield S, Wargo J, Wei P, McNeill L, Gregg JR.   +17 more
europepmc   +1 more source

Final analysis of nivolumab plus cabozantinib for advanced renal cell carcinoma from the randomized phase III CheckMate 9ER trial. [PDF]

Ann Oncol
Motzer RJ, Escudier B, Burotto M, Powles T, Apolo AB, Bourlon MT, Shah AY, Porta C, Suárez C, Barrios CH, Richardet M, Gurney H, Kessler ER, Tomita Y, Bedke J, Scheffold C, Askelson M, Panzica J, Zhang J, van Kooten Losio M, Choueiri TK.   +20 more
europepmc   +1 more source

SGNDV-001: disitamab vedotin with pembrolizumab in HER2-expressing locally advanced or metastatic urothelial carcinoma. [PDF]

Future Oncol
Powles TB, Grande E, Alimohamed N, Oliveira N, Sridhar SS, Drakaki A, Kanesvaran R, Loriot Y, Necchi A, Franco S, Jiang D, Apolinario K, Zhang W, Galsky MD.   +13 more
europepmc   +1 more source